国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2010年
18期
2251-2253
,共3页
赖木乔%梁小波%王任之%张永健
賴木喬%樑小波%王任之%張永健
뢰목교%량소파%왕임지%장영건
洛赛克%思密达%消化性溃疡出血
洛賽剋%思密達%消化性潰瘍齣血
락새극%사밀체%소화성궤양출혈
Losec%Smecta%Peptic ulcer%Hemorrhage
目的 探讨洛赛克联合思密达治疗消化性溃疡出血的临床效果.方法 将2009年1月-2010年1月间在我院治疗的消化性溃疡出血患者60例随机分为观察组和对照组,对照组给予法莫替丁联合立止血治疗,观察组给予洛赛克联合思密达治疗.结果 治疗后观察组腹痛缓解时间及止血时间明显短于对照组,两组比较差异有显著性(P<0.05).观察组总有效率为96.67%,对照组为73.33%,两组比较差异有显著性(P<0.05).观察组有1例用药时出现轻度胸闷,两组患者均未见明显的药物不良反应.结论 洛赛克联合思密达治疗消化性溃疡出血的临床效果肯定,值得应用.
目的 探討洛賽剋聯閤思密達治療消化性潰瘍齣血的臨床效果.方法 將2009年1月-2010年1月間在我院治療的消化性潰瘍齣血患者60例隨機分為觀察組和對照組,對照組給予法莫替丁聯閤立止血治療,觀察組給予洛賽剋聯閤思密達治療.結果 治療後觀察組腹痛緩解時間及止血時間明顯短于對照組,兩組比較差異有顯著性(P<0.05).觀察組總有效率為96.67%,對照組為73.33%,兩組比較差異有顯著性(P<0.05).觀察組有1例用藥時齣現輕度胸悶,兩組患者均未見明顯的藥物不良反應.結論 洛賽剋聯閤思密達治療消化性潰瘍齣血的臨床效果肯定,值得應用.
목적 탐토락새극연합사밀체치료소화성궤양출혈적림상효과.방법 장2009년1월-2010년1월간재아원치료적소화성궤양출혈환자60례수궤분위관찰조화대조조,대조조급여법막체정연합립지혈치료,관찰조급여락새극연합사밀체치료.결과 치료후관찰조복통완해시간급지혈시간명현단우대조조,량조비교차이유현저성(P<0.05).관찰조총유효솔위96.67%,대조조위73.33%,량조비교차이유현저성(P<0.05).관찰조유1례용약시출현경도흉민,량조환자균미견명현적약물불량반응.결론 락새극연합사밀체치료소화성궤양출혈적림상효과긍정,치득응용.
Objective To explore the efficacy of losec combined with smecta in the treatment of peptic ulcer hemorrhage. Methods 60 patients with peptic ulcer hemorrhage in our hospital from January 2009 to January 2010 were randomly assigned to receive combination therapy with famotidine and reptilase (control group),or losec combined with smecta (study group). Results The time to stomachache relief and time to hemostasis were shorter in the study group than in the control group,and there was a significant difference between the two groups (P<0.05). The total effective rate differed significantly between the study group and the control group (96.67% vs. 73.33%,P<0.05). No marked adverse reactions were found in the two groups,except that one patient had mild chest distress in the study group.Conclusions Losec combined with smecta is effective in the treatment of peptic ulcer hemorrhage and thus is worth being used.